BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 30611870)

  • 1. Compounds targeting class II histone deacetylases do not cause panHDACI-associated impairment of megakaryocyte differentiation.
    Simic D; Sang N
    Exp Hematol; 2019 Apr; 72():36-46. PubMed ID: 30611870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of HDAC inhibitor-induced thrombocytopenia.
    Matsuoka H; Unami A; Fujimura T; Noto T; Takata Y; Yoshizawa K; Mori H; Aramori I; Mutoh S
    Eur J Pharmacol; 2007 Oct; 571(2-3):88-96. PubMed ID: 17628529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Panobinostat (LBH589)-induced acetylation of tubulin impairs megakaryocyte maturation and platelet formation.
    Iancu-Rubin C; Gajzer D; Mosoyan G; Feller F; Mascarenhas J; Hoffman R
    Exp Hematol; 2012 Jul; 40(7):564-74. PubMed ID: 22381681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HDACI-induced thrombocytopenia is caused by its unexpected target.
    Kitamura T; Inoue D
    Exp Hematol; 2012 Sep; 40(9):695-7. PubMed ID: 22771790
    [No Abstract]   [Full Text] [Related]  

  • 5. Deciphering the molecular and biologic processes that mediate histone deacetylase inhibitor-induced thrombocytopenia.
    Bishton MJ; Harrison SJ; Martin BP; McLaughlin N; James C; Josefsson EC; Henley KJ; Kile BT; Prince HM; Johnstone RW
    Blood; 2011 Mar; 117(13):3658-68. PubMed ID: 21292776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical role of the HDAC6-cortactin axis in human megakaryocyte maturation leading to a proplatelet-formation defect.
    Messaoudi K; Ali A; Ishaq R; Palazzo A; Sliwa D; Bluteau O; Souquère S; Muller D; Diop KM; Rameau P; Lapierre V; Marolleau JP; Matthias P; Godin I; Pierron G; Thomas SG; Watson SP; Droin N; Vainchenker W; Plo I; Raslova H; Debili N
    Nat Commun; 2017 Nov; 8(1):1786. PubMed ID: 29176689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tubacin, an HDAC6 Selective Inhibitor, Reduces the Replication of the Japanese Encephalitis Virus via the Decrease of Viral RNA Synthesis.
    Lu CY; Chang YC; Hua CH; Chuang C; Huang SH; Kung SH; Hour MJ; Lin CW
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28468311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valproic acid triggers erythro/megakaryocyte lineage decision through induction of GFI1B and MLLT3 expression.
    Zini R; Norfo R; Ferrari F; Bianchi E; Salati S; Pennucci V; Sacchi G; Carboni C; Ceccherelli GB; Tagliafico E; Ferrari S; Manfredini R;
    Exp Hematol; 2012 Dec; 40(12):1043-1054.e6. PubMed ID: 22885124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Megakaryocyte lineage development is controlled by modulation of protein acetylation.
    Bartels M; Govers A; Polak R; Vervoort S; van Boxtel R; Pals C; Bierings M; van Solinge W; Egberts T; Nieuwenhuis E; Mokry M; Coffer PJ
    PLoS One; 2018; 13(4):e0196400. PubMed ID: 29698469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombocytopenia induced by the histone deacetylase inhibitor abexinostat involves p53-dependent and -independent mechanisms.
    Ali A; Bluteau O; Messaoudi K; Palazzo A; Boukour S; Lordier L; Lecluse Y; Rameau P; Kraus-Berthier L; Jacquet-Bescond A; Lelièvre H; Depil S; Dessen P; Solary E; Raslova H; Vainchenker W; Plo I; Debili N
    Cell Death Dis; 2013 Jul; 4(7):e738. PubMed ID: 23887629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acetylation of Hsp90 reverses dexamethasone-mediated inhibition of insulin secretion.
    Zhu K; Zhang Y; Zhang J; Zhou F; Zhang L; Wang S; Zhu Q; Liu Q; Wang X; Zhou L
    Toxicol Lett; 2020 Mar; 320():19-27. PubMed ID: 31778773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitors of histone deacetylases in class I and class II suppress human osteoclasts in vitro.
    Cantley MD; Fairlie DP; Bartold PM; Rainsford KD; Le GT; Lucke AJ; Holding CA; Haynes DR
    J Cell Physiol; 2011 Dec; 226(12):3233-41. PubMed ID: 21344383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of Ets-1 in human hematopoietic progenitor cells blocks erythroid and promotes megakaryocytic differentiation.
    Lulli V; Romania P; Morsilli O; Gabbianelli M; Pagliuca A; Mazzeo S; Testa U; Peschle C; Marziali G
    Cell Death Differ; 2006 Jul; 13(7):1064-74. PubMed ID: 16294212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small-molecule inhibition of proteasome and aggresome function induces synergistic antitumor activity in multiple myeloma.
    Hideshima T; Bradner JE; Wong J; Chauhan D; Richardson P; Schreiber SL; Anderson KC
    Proc Natl Acad Sci U S A; 2005 Jun; 102(24):8567-72. PubMed ID: 15937109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of novel HDAC inhibitors on urothelial carcinoma cells.
    Kaletsch A; Pinkerneil M; Hoffmann MJ; Jaguva Vasudevan AA; Wang C; Hansen FK; Wiek C; Hanenberg H; Gertzen C; Gohlke H; Kassack MU; Kurz T; Schulz WA; Niegisch G
    Clin Epigenetics; 2018 Jul; 10(1):100. PubMed ID: 30064501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent progress in the development of histone deacetylase inhibitors as anti-cancer agents.
    Zhang L; Lei J; Shan Y; Yang H; Song M; Ma Y
    Mini Rev Med Chem; 2013 Dec; 13(14):1999-2013. PubMed ID: 24160707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The histone deacetylase-6 inhibitor tubacin directly inhibits de novo sphingolipid biosynthesis as an off-target effect.
    Siow D; Wattenberg B
    Biochem Biophys Res Commun; 2014 Jul; 449(3):268-71. PubMed ID: 24835950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of histone deacetylases by Trichostatin A leads to a HoxB4-independent increase of hematopoietic progenitor/stem cell frequencies as a result of selective survival.
    Obier N; Uhlemann CF; Müller AM
    Cytotherapy; 2010 Nov; 12(7):899-908. PubMed ID: 20210674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
    Gehling UM; Ryder JW; Hogan CJ; Hami L; McNiece I; Franklin W; Williams S; Helm K; King J; Shpall EJ
    Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Murine hematopoietic stem cell dormancy controlled by induction of a novel short form of PSF1 by histone deacetylase inhibitors.
    Han Y; Gong ZY; Takakura N
    Exp Cell Res; 2015 Jun; 334(2):183-93. PubMed ID: 25933513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.